Connect with us

Health & Society

Users of Antidepressants may suffer due to Doctors not knowing new Research and Guidelines

Published

on

users-of-antidepressants-may-suffer-due-to-doctors-not-knowing-new-research-and-guidelines

Research show people using antidepressants have problems withdrawing from the drugs due to doctors not knowing how to do it correctly, and that it can take months and years due to severe withdrawal effects. Adverse withdrawal effects often are not recognized or misdiagnosed as relapse.

Millions affected

When the SSRI antidepressants first appeared on the market they were presented as drugs that could solve life situations and with no problems related to them. In fact, manufacturers distributed numerous papers with description of withdrawal symptoms from the drugs as being “brief and mild”, based on studies conducted by the drug companies themselves which focused on people who had been on the antidepressants for only 8 to 12 weeks. The result has been that over the years both doctors and the general population have come to believe these drugs can not cause severe and long-lasting withdrawal symptoms on stopping them. And further that stopping the use of these drugs following a treatment would not be a problem.

What has not been the focus in research is that the longer people are on these antidepressants, the harder it is to stop and the more severe the withdrawal effects.

Research presented at this year’s European Psychiatric Congress show there are major problems related to this and research indicate that more than half will have problems stopping, amounting to millions in Europe being affected.

Antidepressants cause residual change to cell structure

The use of antidepressants causes changes to the body and its ability to regulate the use of its own neurotransmitters used to control numerous bodily functions. The result of this change of the cell structures is that once a user has stopped the antidepressants this can cause withdrawal effects and these can last months or years after the drug has left the system. The new research explain what many users have said they have felt for years.

Dr Mark Horowitz, an expert and Clinical Research Fellow in Psychiatry at the National Health Service (NHS) in England, presented extensive research findings that put a new light to the problem.

“When you stop the drug, let’s say months or years after the patient had been started on drug treatment following a stressful period in their life, the antidepressant is metabolized by the liver and kidneys in a few days or weeks. But what doesn’t change in a few days or weeks is the residual changes to the post-synaptic serotonin receptors and other systems downstream of this,” Dr. Horowitz told.

In studies on humans, there are changes to the serotonergic system that persists for up to four years after the antidepressants are stopped.

“In other words, you now have a system that is less sensitive to serotonin being exposed to normal levels of serotonin after the drug is removed. And overall, this could be seen as a low serotonin syndrome,” he clarified.

This of course is a very simplified version of what’s going on. There are many other neurotransmitters and downstream effects of these changes that may also persist for long periods after the drug is stopped. All of these changes also are likely to explain the wide-ranging and long-lasting symptoms that occur after stopping antidepressants.

Adaptation to the drug

Dr Horowitz presenting findings on antidepressant withdrawal. Image: THIX Photo.

The underlying problem that has often been neglected is that years of use has caused an adaptation to the antidepressant drug by the body and brain and this condition persists for longer than it takes the drug to be eliminated from the body, and that’s what causes withdrawal effects.

Dr Mark Horowitz explains why withdrawal effects last for more than a few days or weeks after the drug is out of the system, “it’s not the time taken for the drug to leave the system that determines the length of the effect. It’s the time taken for the system to readapt to the drug not being there that explains how long withdrawal symptoms can last for.”

Antidepressant withdrawal syndrome is a set of physiological symptoms that occur on stopping or reducing the dose of an antidepressant. They can manifest in either psychological or physical symptoms because these drugs affect so many bodily systems. They occur because adaptations to the brain caused by the drug take time to resolve.

Dr Mark Horowitz pointed out that it’s important to understand that withdrawal symptoms do not require addiction, all that is required is adaptation to the drug. This is often referred to as physical dependence. Physical dependence in pharmacological terms means the process of adaptation to appear to exposure to a drug that affects the brain, which is true for antidepressants (and, for example, to caffeine, which does not generally cause addiction but can cause physical dependence and therefore withdrawal effects).

As the SSRI antidepressants act on a neurotransmitter mechanism that influence not only mood but many bodily systems withdrawing from the drug after years of adaptation thus can cause strong reactions on many of these functions and their influence on one’s life.

Symptoms of withdrawal

There are dozens and dozens of possible effects that can be caused. Symptoms include dizziness, insomnia, impaired concentration, fatigue, headache, tremor, tachycardia, and nightmares. Withdrawal can even cause affective symptoms such as depressed mood, irritability, anxiety, and panic attacks.

“We know that these are symptoms of withdrawal and not just relapse (a return of someone’s underlying condition), because they have been found in studies of people who stopped antidepressants with no underlying mental health conditions,” Dr Mark Horowitz told. He mentioned examples such as people who are given these drugs for pain, for the menopause, and even in healthy volunteers.

There are other effects including an increase in suicide attempts in the two weeks after stopping antidepressants. It has been attributed to withdrawal effects itself because it’s too quick for relapse to explain this increase in symptoms. Dr Mark Horowitz further noted that they have also found in studies that while 30% of those who responded were suicidal before starting medication, 60% became suicidal after stopping so that this means for 30% of people they will experience being suicidal for the first time in their lives because of withdrawal effects.

The maybe most disturbing symptom from withdrawal of antidepressants, which often has been neglected, is a condition known as akathisia. Akathisia is a movement disorder usually caused by a psychoactive substance in which the individual generally will experience an intense sensation of unease or an inner restlessness that often prompts the patient to pace backwards and forwards and can be an intensely unpleasant experience. Dr Mark Horowitz noted that it is often recognised as a long-term consequence of antipsychotic exposure, but withdrawal from antidepressants and benzodiazepines and a variety of other psychiatric drugs can also cause the condition.

“It is the most horrible presentations that I see. People are pacing, they feel agitated, they feel terror. A lot of them are talking about suicide because it is a state in which you get no rest and no calm, often for weeks and sometimes longer,” Dr Mark Horowitz pointed out.

And it’s important as this condition is often misdiagnosed when people are presented to the emergency department as agitated depression, as mania, because many clinicians and others are unfamiliar with the fact that coming off these drugs can cause akathisia.

Withdrawal effects not recognized or misdiagnosed as relapse

Tens of thousands users of antidepressants from Europe every month are seeking information and advice from American peer support forums on how to come off their medications. Their stories are for many very similar.

The research group of Dr Mark Horowitz surveyed 1,300 of these. Three quarters of them said their doctor’s advice on withdrawing was unhelpful.

The major reasons where that the doctor had recommended a rate of reduction that was much too quick. And that the treating doctors weren’t familiar enough with withdrawal symptoms to have any advice, or they told the user that stopping with antidepressants would not cause withdrawal symptoms.

Dr Mark Horowitz indicated that doctors often still believe that withdrawal effects from antidepressants are “brief and mild”. And they do not know that withdrawal symptoms include anxiety, depressed mood, and insomnia.

“It’s easy to confuse with a relapse of depression or anxiety, especially when it’s in the clinician’s minds that withdrawal effects are brief and mild. Someone turns up with severe symptoms that are long lasting, it’s very hard to put the connection together,” Dr Mark Horowitz added.

Another disturbing fact is that withdrawal effects is not only related to antidepressants. “The same is true for coming off of all psychiatric drugs. Often the changes produced on the brain by psychiatric drugs can persist for months or years after stopping, which is why withdrawal syndromes can last a lot longer if it takes the drug to be eliminated from the body,” Dr Mark Horowitz pointed out.

Author

Health & Society

EU treading Dangerous Waters: The Perils of Psychedelics in Therapeutic Use

Published

on

The European Commission is getting ready to review citizens’ proposals and one controversial idea on the table is the ‘PsychedeliCare’ initiative that supports the exploration and implementation of psychedelic treatments for mental wellbeing issues. Advocates of this initiative highlight the advantages of using psychedelics in addressing mental health concerns; however it’s crucial to carefully assess the consequences of making these substances mainstream for therapeutic use, it already happened with way too many “pharma products” and end up being dangerous street drugs, as this is what they actually were from the beginning.

The Illusory Promise of Psychedelics

Supporters of this “therapies” frequently promote these substances as amazing remedies for profound mental health challenges like depression and anxiety disorders such as PTSD are regularly highlighted by them in support of their claims. However, these early research findings are willfully misinterpreted and exaggerated. The “positive outcomes” observed in limited research studies do not automatically translate to safety and effectiveness across wider and more varied demographic groups, often the contrary. Throughout history the fascination with a quick fix for mental health issues has often resulted in disappointment and harm, if not death.

A Lack of Comprehensive Understanding

The insufficient scientific knowledge about psychedelics raises concerns within the community as the intricate workings of the human brain remain a mystery when influenced by these substances. There are risks such as psychological distress and worsening of preexisting mental health conditions that make it unthinkable to integrate psychedelics into mainstream therapy practices at all. It is crucial to acknowledge the variations in individual experiences and biological compositions to prevent unintended harm rather than aiding in treatment efforts.

Regulatory and Ethical Concerns

The push for government endorsement of psychedelic therapies raises numerous ethical questions. Should substances with known psychoactive properties be part of mainstream health care? The regulatory environment surrounding these compounds is fraught with challenges, including ensuring quality control, standardizing dosages, and preventing misuse. With the legalization movements in various regions, the potential for recreational abuse expands, risking public health and safety.

Historical Context and Social Implications

Looking back, the late 1960s and early 1970s were marked by a psychedelic counterculture that resulted in societal turmoil and increased drug abuse. The legacy of this era still looms large; many young individuals romanticize psychedelic use without regarding the severe consequences that accompanied its earlier popularity, including addiction, mental health crises, and a societal disregard for safety protocols.

A Dangerous Precedent

By calling for a more prominent role for psychedelics in treatment protocols, the advocates of the ‘PsychedeliCare’ initiative may unintentionally set a dangerous precedent. Replacing established, evidence-based treatments with unproven psychedelic therapies could detract from the very real progress made in mental health care. It could shift focus away from holistic approaches that consider lifestyle, therapeutic counseling, and medication tailored to individual needs.

Conclusion

The debate surrounding the ‘PsychedeliCare’ initiative should prompt a vigilant and cautious examination of the implications of endorsing psychedelics as treatment options. While there is a critical need for innovative approaches in mental health care, rushing to embrace unproven therapies poses significant risks. It is paramount that we prioritize rigorous scientific scrutiny, ethical considerations, and the well-being of individuals over the allure of quick solutions. The only clear path forward is one grounded in proven therapies, comprehensive research, and unwavering commitment to public health.

Author

Continue Reading

Health & Society

Why chocolate should not be given to dogs

Published

on

Chocolate is a favorite delicacy for people, but for cats and dogs it is a real poison, writes the magazine ” Sciences et Avenir” and explains why pets should not be “pampered” with chocolate under any circumstances.

For them, chocolate is toxic, because it is not properly absorbed by their body. This is due to the alkaloid theobromine, which is contained in cocoa and therefore in chocolate.

The substance becomes dangerous to health when large amounts of it are stored in the liver. About 12 grams of theobromine are contained in dark chocolate, twice as much in milk chocolate, and very small amounts in white chocolate.

Theobromine does not harm humans, as the human body manages to break it down quickly.

However, it takes 20 hours for dogs to get rid of this molecule. It can build up in their liver and cause poisoning if large amounts of chocolate are ingested at once.

Among the symptoms are vomiting, diarrhea, rapid pulse, convulsions.

The same is true for cats. However, they are less attracted to chocolate than dogs because they cannot taste sweets with their tongues, although there are exceptions.

In addition, pet obesity is the subject of a number of educational campaigns aimed at owners.

A court in North West England has banned a British man from keeping pets for the next 10 years because his Dalmatian became too fat. wrote the English tabloid “Sun” in November 2009.

40-year-old man John Green, a resident of Macclesfield in Cheshire, showed extreme irresponsibility towards his dog Barney and fed him chips and chocolate.

Thus, in just three months, it became several times fatter than normal for its breed and reached 70 kg.

Green was tipped off by alarmed, vigilant fellow citizens.

Animal control officials warned Green that his dog’s health was in danger and recommended that he be put on a diet.

However, he did not follow the recommendations and the dog continued to gain weight.

The Dalmatian was eventually removed from his owner’s home in June and put on a diet in a private kennel, where staff made sure he got enough exercise.

As a result, Barney, who is eight years old, lost 40 kg.

Green pleaded guilty to causing his dog unnecessary suffering, but the court found some mitigating circumstances because the man treated Barney more like a friend than a dog and did not realize he was harming him.

That’s why Green was only sentenced to 200 hours of community service and to pay £780 in costs.

Illustrative Photo by Glenn: https://www.pexels.com/photo/high-angle-photo-of-a-corgi-looking-upwards-2664417/

Author

Continue Reading

Health & Society

Russian Orthodox Church calls on mass culture to abandon ‘images promoting alcoholism’

Published

on

On the occasion of the Day of Sobriety celebrated in the country today, the Russian Orthodox Church called on mass culture not to promote alcoholism, TASS reported.

The agency recalls that the All-Russian Day of Sobriety is celebrated on the initiative of the Russian Orthodox Church on September 11 to remind people of the harm caused by alcohol. On this day, in some parts of Russia, the sale of alcohol is limited or completely prohibited.

“The culture of attitude towards this is very important. There are many “nice jokes” about alcoholism in our everyday culture. There is nothing good about that. We know what the state of intoxication leads to. Those who deal with mass culture should make an effort that the image of the “dear drunkard” should still leave our mass culture,” said the head of the synodal department of the Moscow Patriarchate for Church Interaction on the sidelines of the St. Petersburg Forum of United Cultures with society and media Vladimir Legoida.

Asked whether it would be appropriate to ban or restrict the sale of alcohol across the country, he said “that would be wonderful”. “But it is important that people do this consciously, independently, not because someone is forcing them, and also that there is, as it is customary to say, a public consensus,” he stated.

Legoida noted that the category of “sobriety” is important for the church in general, which refers not only to abstinence from alcohol.

Meanwhile, during a press conference dedicated to the All-Russian Day of Sobriety, Russia’s Deputy Health Minister Oleg Salagai said that alcohol abuse can reduce a man’s life expectancy by six years and a woman by five years.

“The systemic measures that were adopted allowed us to really reduce alcohol consumption. Today, it can be confidently said that Russia is not one of the most drinking countries in the world,” said the deputy minister, who pointed out that in 2023 alcohol consumption in the country was about 8.4 liters per person, while at the beginning of the century the indicator was in double digits.

Illustrative Photo by EVG Kowalievska: https://www.pexels.com/photo/selective-focus-photography-of-assorted-brand-liquor-bottles-1128259/

Author

Continue Reading

Trending

Copyright © 2023 EuroTimes

Exit mobile version